Atai Therapeutics patents new 5-HT2 receptor agonists

AI Briefing

• – Atai Therapeutics identifies new 5-HT2 receptor agonists for psychiatric disorders
• – Potential treatment for psychiatric disorders
• – New 5-HT2 receptor agonists